by Emerson Dameron, on December 15,2017
by Emerson Dameron, on December 15,2017
Recently, Volumetric Absorptive Microsampling (VAMS™) technology helped a group of organ transplant patients summit Mt. Kilimanjaro. Now students and scientists from the biomedical engineering program at Duke University have found another transformative new use case: testing children in Liberia for biomarkers associated with malnutrition.
Over the summer, Daniel Joh, an MD-PhD student at Duke, and Angus Hucknall, a senior research scientist, touched down in New Kru Town, a neighborhood in the outer reaches of Monrovia, Liberia. They were there to field test diagnostic tools designed to rapidly measure the biomarkers linked to malnutrition. In this low-resourced reigion, they set up shop at Redemption Clinic, and made use of some revolutionary medical innovations to do their work under subprime conditions. Read more.
The latest product releases, company news and microsampling industry updates from Neoteryx.
If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com
Fact Sheet & FAQs
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022. All rights reserved.